Cargando…
Correlation between urinary GAG and anti-idursulfase ERT neutralizing antibodies during treatment with NICIT immune tolerance regimen: A case report(,)
INTRODUCTION: Antibodies to intravenous idursulfase enzyme replacement therapy (ERT) for patients with Hunter syndrome (mucopolysaccharidosis type II, MPS II) can have a harmful clinical impact, including both increasing risk of infusion reactions and inhibiting therapeutic activity. Thus, failure t...
Autores principales: | Kim, Sarah, Whitley, Chester B., Jarnes Utz, Jeanine R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5798249/ https://www.ncbi.nlm.nih.gov/pubmed/28610913 http://dx.doi.org/10.1016/j.ymgme.2017.06.001 |
Ejemplares similares
-
Genotype-phenotype correlation of gangliosidosis mutations using in silico tools and homology modeling
por: Ou, Li, et al.
Publicado: (2019) -
The juvenile gangliosidoses: A timeline of clinical change
por: King, Kelly E., et al.
Publicado: (2020) -
Comparative study of idursulfase beta and idursulfase in vitro and in vivo
por: Kim, Chihwa, et al.
Publicado: (2017) -
Hypothyroidism in late-onset Pompe disease
por: Schneider, Joseph, et al.
Publicado: (2016) -
Distinct progression patterns of brain disease in infantile and juvenile gangliosidoses: Volumetric quantitative MRI study
por: Nestrasil, Igor, et al.
Publicado: (2017)